Literature DB >> 10211960

Identification of a new element for RNA replication within the internal ribosome entry site of poliovirus RNA.

T Ishii, K Shiroki, A Iwai, A Nomoto.   

Abstract

Several mutants of the Mahoney strain of poliovirus type 1 have been generated by introducing mutations into the stem-loop II (SLII) structure within the internal ribosomal entry site (IRES). Four of these mutants (SLII-1, -4, -5 and -6 mutants) have been characterized previously and are host-range mutants that replicate well in human HeLa cells but not in mouse cells. Two deletion mutants, SLII-2 and SLII-3, were non-viable, even in HeLa cells. It is now reported that SLII-2 was defective in genome RNA synthesis and viral protein synthesis, while SLII-3 was defective only in viral protein synthesis. These results indicate that the SLII region contains a cis-element for RNA replication as well as for IRES-dependent translation and that these two functions lie at the same sites within the SLII region. The host cellular factors that interacted with wild-type SLII and mutant SLII-2 and SLII-3 RNAs were different, suggesting that different host-factor binding regulates expression of mutant phenotypes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10211960     DOI: 10.1099/0022-1317-80-4-917

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  15 in total

1.  Identification of an RNA hairpin in poliovirus RNA that serves as the primary template in the in vitro uridylylation of VPg.

Authors:  A V Paul; E Rieder; D W Kim; J H van Boom; E Wimmer
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  Cross-talk between orientation-dependent recognition determinants of a complex control RNA element, the enterovirus oriR.

Authors:  W J Melchers; J M Bakkers; H J Bruins Slot; J M Galama; V I Agol; E V Pilipenko
Journal:  RNA       Date:  2000-07       Impact factor: 4.942

3.  Replication of poliovirus RNA with complete internal ribosome entry site deletions.

Authors:  Kenneth E Murray; Benjamin P Steil; Allan W Roberts; David J Barton
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

4.  The 5'-terminal region of the Aichi virus genome encodes cis-acting replication elements required for positive- and negative-strand RNA synthesis.

Authors:  Shigeo Nagashima; Jun Sasaki; Koki Taniguchi
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

5.  Sequences in the 5' nontranslated region of hepatitis C virus required for RNA replication.

Authors:  P Friebe; V Lohmann; N Krieger; R Bartenschlager
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

6.  A predicted secondary structural domain within the internal ribosome entry site of echovirus 12 mediates a cell-type-specific block to viral replication.

Authors:  S S Bradrick; E A Lieben; B M Carden; J R Romero
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

7.  Mutation of a single conserved nucleotide between the cloverleaf and internal ribosome entry site attenuates poliovirus neurovirulence.

Authors:  Nidia De Jesus; David Franco; Aniko Paul; Eckard Wimmer; Jeronimo Cello
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

Review 8.  Role of RNA structure motifs in IRES-dependent translation initiation of the coxsackievirus B3: new insights for developing live-attenuated strains for vaccines and gene therapy.

Authors:  Amira Souii; Manel Ben M'hadheb-Gharbi; Jawhar Gharbi
Journal:  Mol Biotechnol       Date:  2013-10       Impact factor: 2.695

9.  Genetic analysis of a poliovirus/hepatitis C virus chimera: new structure for domain II of the internal ribosomal entry site of hepatitis C virus.

Authors:  W D Zhao; E Wimmer
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

10.  Structure of the 5' nontranslated region of the coxsackievirus b3 genome: Chemical modification and comparative sequence analysis.

Authors:  Jennifer M Bailey; William E Tapprich
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.